Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...

Márcio Temtem, Hovione, discusses how to tackle pharma complexity via regional growth in the US, Ireland, and Portugal, using digital tools to accelerate development.

Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

The FDA's requirements that are nowhere to be found in the law creaties uncertainty for companies with pending vaccine ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Tagline: Empowering Global Innovative Biologics R&D through Ecosystem Strength SHANGHAI, /PRNewswire/ -- On February 8, at ...

Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...

While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the ...